DrugMar 26, 2025
Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg) recall — FDA D-0291-2025
Super-Potent Drug: Out of specification potency results were obtained.
Class IIFDA: OngoingMylan Institutional, Inc.
Recall history in this database
Classification mix: Class II: 8.
DrugMar 26, 2025
Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg) recall — FDA D-0290-2025
Super-Potent Drug: Out of specification potency results were obtained.
Class IIFDA: OngoingMylan Institutional, Inc.
DrugDec 18, 2024
Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 100 Tablets per carton recall — FDA D-0133-2025
Subpotent and Superpotent Drug
Class IIFDA: OngoingMylan Institutional, Inc.
DrugDec 18, 2024
Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 100 Tablets per carton recall — FDA D-0136-2025
Subpotent and Superpotent Drug
Class IIFDA: OngoingMylan Institutional, Inc.
DrugDec 18, 2024
Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), 100 Tablets per carton recall — FDA D-0131-2025
Subpotent and Superpotent Drug
Class IIFDA: OngoingMylan Institutional, Inc.
DrugDec 18, 2024
Levothyroxine Sodium Tablets, USP, 150 mcg (0.150 mg), 100 Tablets per carton recall — FDA D-0135-2025
Subpotent and Superpotent Drug
Class IIFDA: OngoingMylan Institutional, Inc.
DrugDec 18, 2024
Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 100 Tablets per carton recall — FDA D-0132-2025
Subpotent and Superpotent Drug
Class IIFDA: OngoingMylan Institutional, Inc.
DrugDec 18, 2024
Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), 100 Tablets per carton recall — FDA D-0134-2025
Subpotent and Superpotent Drug
Class IIFDA: OngoingMylan Institutional, Inc.
Understanding this recall history
This page summarizes recall records in which the official source identifies Mylan Institutional, Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.